GASTROINTESTINAL CANCER: Promising results from a small phase Ib study of regorafenib + nivolumab in advanced gastric or colorectal cancer: ORR 44% & 36% respectively

by OncoDNA

4 years ago
regorafenib, gastrointestinal, colorectal, cancer

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

An inflammatory diet correlates with colorectal cancer risk

by Hospital Universitari de Bellvitge

5 years ago
cancer, diet, colorectal, inflammatory

The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual

Successful start of the clinical validation study of COLODETECT®, a blood-based diagnostic test for early detection of colorectal cancer

by Protein Alternatives SL (PROALT)

5 years ago
cancer, COLODETECT, diagnostic, test, detection, colorectal

Protein Alternatives S.L. (PROALT) has begun the clinical validation study of its blood-based diagnostic test for colorectal cancerin Luminex® and ELISA-based formats. COLODETECT® test is based on...

IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer

by IBEC - Institut de Bioenginyeria de Catalunya

5 years ago
therapies, Cancer, colorectal

The discovery is based on targeting the tissue surrounding the tumor, instead of the tumor directly

Scientists confirm the validity of current techniques for predicting resistance to treatment in metastatic colorectal cancer

by IBEC - Institut de Bioenginyeria de Catalunya

5 years ago
drug resistance, Cancer, colorectal

Researchers from IDIBELL and ICO show that current mutational analysis techniques are sufficiently sensitive to predict resistance to treatment with EGFR inhibitors in metastatic colorectal cancer